FIELD: medicine, ophthalmology. SUBSTANCE: invention relates to agent used for prophylaxis or treatment of diseases associated with abnormal proliferation of epithelial pigment cells of retina, such as proliferative vitreoretinopathy. Agent comprises N-(3,4-dimethoxycinnamoyl)anthranilic acid of the formula (I) or its pharmaceutically acceptable salt as an active component. EFFECT: enhanced effectiveness of agent. 5 cl, 1 tbl
Authors
Dates
2003-07-10—Published
1998-04-10—Filed